Well, I have one comment. I hate to use names, but Mr. Dornan was the person who used the expression “cherry-picking”. Madame Richard accused me of being part of a sordid plot to administer experimental drugs and vaccines. I don't like hearing things like this, but at the same time I can understand their frustrations, so I don't take it personally. That's just as an opening remark.
With respect to the cherry-picking.... Incidentally, Mr. Dornan, when he appeared before our committee, gave us a stack of documents and articles that he had prepared. He and his wife are very good at this. I really admire their tenacity and how they look at this. I personally looked at every single page of that stack. We did not include all of them because some of them were minor studies, minor not in the sense of mining, but they were not major studies.
The one study, and I have to comment on this one because it merits a second look. He mentioned that the milestone studies were the French studies. I remember that in his testimony. He said, “They overlooked the French studies.” He said, “This is what they showed.” I thought, “God, you know, I looked at that study, but I didn't get that conclusion.” I went back to the original article yesterday. I thought, “Darn it, I'm going to read that. What did we miss, collectively?” In fact, we had read the article. We're not wrong in any way. It appears the findings are right there in the report—on page 19 or 20; I can't remember, but they're there. The references are there, and they were in fact considered.
The one report that he said was revolutionary dealt not with depleted uranium but with reprocessed uranium. That is enriched uranium, not depleted uranium, that was being reprocessed. It has plutonium, americium, all kinds of other things, so I don't think it's very germane to the study. Plus it was a pilot study. They reported that as a pilot study, an initial pilot study, and they said that yes, they have some indication that perhaps there may be some increased cancers of a hematopoietic effect, which are multiple lymphomas. Fine. We think there may be. It is suggestive—that's their word—but we have to look at it more carefully.
The other thing I want to mention is that one of the co-authors of that study is one of our reviewers. He agreed with our conclusions, and he agreed it was complete, and so on and so forth. You're asking me to set the record straight on that. We did not cherry-pick, no.